1518P An individualized model-based risk score is the best prognostic tool for localized soft tissue sarcoma (STS) cases, but clinical status cannot be neglected

Autor: Teterycz, P., Kosela Paterczyk, H.M., Jagodzinska-Mucha, P., Mariuk-Jarema, A., Sobczuk, P., Kozak, K., Rogala, P., Wagrodzki, M., Switaj, T., Łysikowska, W., A. klimczak, Rutkowski, P.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S1240-S1240
Databáze: ScienceDirect